miR-34a up-regulation in a transgenic mice model of Alzheimer’s disease resulted in a higher expression level of activated caspase-3 protein by inhibiting bcl-2 translation, suggesting that bcl-2 is an important target for miR-34a [22]. This evidence concerns the gene CASP3 and early-onset autosomal dominant Alzheimer disease.